Clayton, Dubilier & Rice Names FitzGerald As Operating Advisor

Jan 9 2017 | 6:22pm ET

Private equity manager Clayton, Dubilier & Rice (CD&R) has appointed Liam FitzGerald, former CEO of UDG Healthcare Plc, as an operating advisor.

FitzGerald will work out of CD&R’s London office, the company said in a statement. 

As CEO of UDG Healthcare from 2000 until 2016, he expanded the business from a mainly Irish-based distribution services business into a multi-faceted and multi-national healthcare services group operating in 20 countries. During that period, the company’s market capitalization increased by more than 500 percent and earnings grew at a compound annual rate of more than 20 percent. Moreover, FitzGerald is credited with leading and seamlessly integrating more than 30 acquisitions into the parent company. 

“Liam is a recognized leader who has a demonstrated record of driving sustained enterprise growth, market share gains and value creation on a global scale,” said CD&R partner David Novak, in the statement. “He brings valuable healthcare industry expertise, deep market insights and a broad network, particularly in Europe where we are enthusiastic about the investment opportunities presented by strong secular trends in the healthcare space.”

Prior to serving as CEO of UDG Healthcare, Mr. FitzGerald was the company’s director of healthcare supply chain from 1996 until 2000, and was business development manager for the company’s drug distribution unit from 1993 until 1996. 

Founded in 1978, New York-based CD&R is a private investment firm that has managed the investment of $22 billion in 72 businesses since inception.


In Depth

Q&A: Sancus Capital And The Disruption Of The CLO Market

Oct 5 2017 | 6:28pm ET

Traditional collateralized loan obligation (CLO) funds in the U.S. market can offer...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Finding Success as Alternatives Converge

Oct 9 2017 | 4:00pm ET

Rising interest among institutional investors over the past several years has led...

 

From the current issue of